THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,939 | -19.3% | 55,381 | -3.2% | 0.00% | – |
| Q2 2023 | $591,979 | -3.9% | 57,196 | +0.7% | 0.00% | – |
| Q1 2023 | $616,227 | -0.8% | 56,795 | +2.5% | 0.00% | – |
| Q4 2022 | $621,486 | +9.8% | 55,391 | -0.8% | 0.00% | – |
| Q3 2022 | $566,000 | +6.0% | 55,859 | -5.2% | 0.00% | – |
| Q2 2022 | $534,000 | -2.7% | 58,904 | +2.6% | 0.00% | – |
| Q1 2022 | $549,000 | -13.4% | 57,388 | -0.0% | 0.00% | – |
| Q4 2021 | $634,000 | +100.6% | 57,397 | +34.3% | 0.00% | – |
| Q3 2021 | $316,000 | -31.0% | 42,749 | +35.6% | 0.00% | – |
| Q2 2021 | $458,000 | -27.8% | 31,525 | +1.5% | 0.00% | – |
| Q1 2021 | $634,000 | +14.2% | 31,064 | -0.6% | 0.00% | – |
| Q4 2020 | $555,000 | +19.9% | 31,265 | 0.0% | 0.00% | – |
| Q3 2020 | $463,000 | -34.1% | 31,265 | -6.7% | 0.00% | – |
| Q2 2020 | $703,000 | -10.4% | 33,495 | -1.5% | 0.00% | – |
| Q1 2020 | $785,000 | +21.5% | 33,988 | +36.3% | 0.00% | – |
| Q4 2019 | $646,000 | +42.9% | 24,940 | +7.6% | 0.00% | – |
| Q3 2019 | $452,000 | +33.3% | 23,178 | +11.5% | 0.00% | – |
| Q2 2019 | $339,000 | -26.3% | 20,790 | +2.5% | 0.00% | – |
| Q1 2019 | $460,000 | -6.5% | 20,290 | +5.4% | 0.00% | – |
| Q4 2018 | $492,000 | +9.6% | 19,244 | +40.0% | 0.00% | – |
| Q3 2018 | $449,000 | +43.9% | 13,742 | 0.0% | 0.00% | – |
| Q2 2018 | $312,000 | -13.6% | 13,742 | -7.7% | 0.00% | – |
| Q1 2018 | $361,000 | -38.9% | 14,881 | -29.6% | 0.00% | – |
| Q4 2017 | $591,000 | -8.5% | 21,140 | +12.2% | 0.00% | – |
| Q3 2017 | $646,000 | -0.5% | 18,840 | +15.7% | 0.00% | -100.0% |
| Q2 2017 | $649,000 | +12.7% | 16,289 | +3.7% | 0.00% | – |
| Q1 2017 | $576,000 | +28.6% | 15,713 | +11.6% | 0.00% | – |
| Q4 2016 | $448,000 | – | 14,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |